Literature DB >> 1549129

Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src.

C Seidel-Dugan1, B E Meyer, S M Thomas, J S Brugge.   

Abstract

The amino-termina, noncatalytic half of Src contains two domains, designated the Src homology 2 (SH2) and Src homology 3 (SH3) domains, that are highly conserved among members of the Src family of tyrosine kinases. The SH2 domain (which can be further divided into the B and C homology boxes) and the SH3 domain (also referred to as the A box) are also found in several proteins otherwise unrelated to protein tyrosine kinases. It is believed that these domains are important for directing specific protein-protein interactions necessary for the proper functioning of Src. To determine the importance of the SH2 and SH3 domains in regulating the functions of c-Src, we evaluated mutants of c-Src lacking the A box (residues 88 to 137), the B box (residues 148 to 187) or the C box (residues 220 to 231). Each of these deletions caused a 14- to 30-fold increase in the in vitro level of kinase activity of c-Src. Chicken embryo fibroblasts expressing the deletion mutants displayed a transformed cell morphology, formed colonies in soft agar, and contained elevated levels of cellular phosphotyrosine-containing proteins. Src substrates p36, p85, p120, p125, the GTPase-activating protein (GAP), and several GAP-associated proteins were phosphorylated on tyrosine in cells expressing the A, B, or C box deletion mutant. p110 was highly phosphorylated in cells expressing the C box mutant, was weakly phosphorylated in cells expressing the B box mutant, and was not phosphorylated in cells expressing the A box mutant. Expression of the mutant proteins caused a reorganization of the actin cytoskeleton similar to that seen in v-Src-transformed cells. In addition, deletion of the A, B, or C box did not diminish the transforming or enzymatic activity of an activated variant of c-Src, E378G. These data indicate that deletion of the A, B, or C homology box causes an activation of the catalytic and transforming potential of c-Src and that while these mutations caused subtle differences in substrate phosphorylation, the homology boxes are not required for many of the phenotypic changes associated with transformation by Src.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549129      PMCID: PMC369627          DOI: 10.1128/mcb.12.4.1835-1845.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.

Authors:  M Matsuda; B J Mayer; Y Fukui; H Hanafusa
Journal:  Science       Date:  1990-06-22       Impact factor: 47.728

2.  Inhibition of the tyrosine kinase activity of v-src, v-fgr, and v-yes gene products by a monoclonal antibody which binds both amino and carboxy peptide fragments of pp60v-src.

Authors:  D J McCarley; J T Parsons; D C Benjamin; S J Parsons
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

3.  Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability.

Authors:  H C Wang; J T Parsons
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Neuronal pp60c-src contains a six-amino acid insertion relative to its non-neuronal counterpart.

Authors:  R Martinez; B Mathey-Prevot; A Bernards; D Baltimore
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728

5.  Investigation of factors that influence phosphorylation of pp60c-src on tyrosine 527.

Authors:  S M Schuh; J S Brugge
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

6.  Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.

Authors:  W M Potts; A B Reynolds; T J Lansing; J T Parsons
Journal:  Oncogene Res       Date:  1988

7.  Biological and biochemical properties of the c-src+ gene product overexpressed in chicken embryo fibroblasts.

Authors:  J B Levy; J S Brugge
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

8.  Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins.

Authors:  A B Reynolds; S B Kanner; H C Wang; J T Parsons
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

9.  Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity.

Authors:  B J Mayer; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  Identification of a novel neuronal C-SRC exon expressed in human brain.

Authors:  J M Pyper; J B Bolen
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

View more
  60 in total

1.  The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

Authors:  C E Andoniou; N L Lill; C B Thien; M L Lupher; S Ota; D D Bowtell; R M Scaife; W Y Langdon; H Band
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.

Authors:  T Yamadori; Y Baba; M Matsushita; S Hashimoto; M Kurosaki; T Kurosaki; T Kishimoto; S Tsukada
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  CR16, a novel proline-rich protein expressed in rat brain neurons, binds to SH3 domains and is a MAP kinase substrate.

Authors:  M C Weiler; J L Smith; J N Masters
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn.

Authors:  Navin Rao; Amiya K Ghosh; Patrice Douillard; Christopher E Andoniou; Pengcheng Zhou; Hamid Band
Journal:  Signal Transduct       Date:  2002-11-07

5.  Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin.

Authors:  M E Noble; A Musacchio; M Saraste; S A Courtneidge; R K Wierenga
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

6.  Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.

Authors:  S M Murphy; M Bergman; D O Morgan
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.

Authors:  G Payne; S E Shoelson; G D Gish; T Pawson; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

8.  Phosphorylation-dependent and phosphorylation-independent modes of modulation of shaker family voltage-gated potassium channels by SRC family protein tyrosine kinases.

Authors:  Michael N Nitabach; D Alberto Llamas; Ian J Thompson; Kerry A Collins; Todd C Holmes
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells.

Authors:  S Tanaka; S Hattori; T Kurata; K Nagashima; Y Fukui; S Nakamura; M Matsuda
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

10.  Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.

Authors:  A D Catling; V J Fincham; M C Frame; B Haefner; J A Wyke
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.